
VivaGel was first tested on monkeys and the findings said that the new gel is superbly efficient in preventing HIV infection. Starpharma also released the results of the first human clinical trial. It stated that the gel is a safe vaginal microbicide that won't produce side effects. It doesn't caused inflammation, irritation, or any
harmful effects to the patients' reproductive organ. Organizers of the said study concluded that VivaGel is safe and tolerable.